
Fine-tuning Llama-2-13B with AI-generated medical diagnoses: A novel strategy for optimizing ICD coding in gynecologic oncology.
AI-Enhanced ICD Coding in Gynecologic Oncology: Llama-2-13B Model Achieves 95% Accuracy! ππ€
Discover the newest research about AI innovations in π Oncology.

AI-Enhanced ICD Coding in Gynecologic Oncology: Llama-2-13B Model Achieves 95% Accuracy! ππ€

Technological advancements in antibody therapeutics: 144 FDA-approved drugs, $267B sales, and AI-driven discoveries. ππ
New AI model improves breast cancer recurrence prediction by analyzing imaging and clinical data. Promising results for patient monitoring. ππ€

AI aids in developing personalized cancer vaccines by identifying neoantigens, enhancing immune response against tumors. π§¬π

Early hypopharyngeal carcinoma: AI and ME-NBI enhance detection; minimally invasive surgery improves outcomes. ππ

AI models predict pain relief in colorectal cancer patients: 73.8% improved, AUC 0.9167. Key insights from PubMed study. ππ

AI model suggests 40% of breast cancer patients may avoid axillary surgery. This could reduce unnecessary procedures. π€π

Automated CT analysis reveals Sarcopenia Index as a key prognostic factor for overall survival in cancer patients. ππͺ
AI tool PICTURE accurately differentiates glioblastoma from similar brain tumors during surgery, aiding timely treatment decisions. π§ π

Immune checkpoint inhibitors revolutionize cancer therapy, yet challenges like efficacy variability and adverse events persist. ππ